Insider Transactions in Q2 2022 at Dexcom Inc (DXCM)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2022
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
1,000
-0.71%
|
$72,000
$72.55 P/Share
|
|
Jun 06
2022
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Open market or private sale
|
Direct |
600
-3.33%
|
$180,600
$301.57 P/Share
|
|
May 24
2022
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
250
-0.71%
|
$74,000
$296.33 P/Share
|
|
May 20
2022
|
Steven R Altman Director |
BUY
Grant, award, or other acquisition
|
Direct |
979
+50.0%
|
-
|
|
May 20
2022
|
Nicholas Augustinos Director |
BUY
Grant, award, or other acquisition
|
Direct |
994
+50.0%
|
-
|
|
May 20
2022
|
Richard Alexander Collins Director |
BUY
Grant, award, or other acquisition
|
Direct |
987
+50.0%
|
-
|
|
May 20
2022
|
Karen M Dahut Director |
BUY
Grant, award, or other acquisition
|
Direct |
987
+35.93%
|
-
|
|
May 20
2022
|
Mark G Foletta Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+50.0%
|
-
|
|
May 20
2022
|
Bridgette P Heller Director |
BUY
Grant, award, or other acquisition
|
Direct |
988
+15.58%
|
-
|
|
May 20
2022
|
Barbara Kahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
994
+50.0%
|
-
|
|
May 20
2022
|
Kyle Malady Director |
BUY
Grant, award, or other acquisition
|
Direct |
979
+23.65%
|
-
|
|
May 20
2022
|
Jay S Skyler Director |
BUY
Grant, award, or other acquisition
|
Direct |
969
+50.0%
|
-
|
|
May 20
2022
|
Eric Topol Director |
BUY
Grant, award, or other acquisition
|
Direct |
988
+50.0%
|
-
|
|
May 19
2022
|
Steven R Altman Director |
BUY
Other acquisition or disposition
|
Indirect |
910
+5.83%
|
-
|
|
May 19
2022
|
Steven R Altman Director |
SELL
Other acquisition or disposition
|
Direct |
910
-100.0%
|
-
|
|
May 19
2022
|
Nicholas Augustinos Director |
BUY
Other acquisition or disposition
|
Indirect |
918
+9.74%
|
-
|
|
May 19
2022
|
Nicholas Augustinos Director |
SELL
Other acquisition or disposition
|
Direct |
918
-100.0%
|
-
|
|
May 19
2022
|
Richard Alexander Collins Director |
BUY
Other acquisition or disposition
|
Indirect |
910
+10.08%
|
-
|
|
May 19
2022
|
Richard Alexander Collins Director |
SELL
Other acquisition or disposition
|
Direct |
910
-100.0%
|
-
|
|
May 19
2022
|
Karen M Dahut Director |
BUY
Other acquisition or disposition
|
Indirect |
918
+41.3%
|
-
|
|
May 19
2022
|
Karen M Dahut Director |
SELL
Other acquisition or disposition
|
Direct |
918
-54.29%
|
-
|
|
May 19
2022
|
Mark G Foletta Director |
BUY
Other acquisition or disposition
|
Indirect |
1,054
+7.17%
|
-
|
|
May 19
2022
|
Mark G Foletta Director |
SELL
Other acquisition or disposition
|
Direct |
1,054
-100.0%
|
-
|
|
May 19
2022
|
Barbara Kahn Director |
BUY
Other acquisition or disposition
|
Indirect |
918
+18.98%
|
-
|
|
May 19
2022
|
Barbara Kahn Director |
SELL
Other acquisition or disposition
|
Direct |
918
-100.0%
|
-
|
|
May 19
2022
|
Jay S Skyler Director |
BUY
Other acquisition or disposition
|
Indirect |
900
+5.71%
|
-
|
|
May 19
2022
|
Jay S Skyler Director |
SELL
Other acquisition or disposition
|
Direct |
900
-100.0%
|
-
|
|
May 19
2022
|
Eric Topol Director |
BUY
Other acquisition or disposition
|
Indirect |
919
+0.98%
|
-
|
|
May 19
2022
|
Eric Topol Director |
SELL
Other acquisition or disposition
|
Direct |
919
-100.0%
|
-
|
|
May 09
2022
|
Chad Patterson EVP Global Marketing |
SELL
Open market or private sale
|
Direct |
777
-5.38%
|
$265,734
$342.77 P/Share
|
|
Apr 25
2022
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
250
-0.7%
|
$109,750
$439.94 P/Share
|
|
Apr 11
2022
|
Chad Patterson EVP Global Marketing |
SELL
Open market or private sale
|
Direct |
776
-5.1%
|
$386,448
$498.75 P/Share
|